loadpatents
Patent applications and USPTO patent grants for Cihlar; Tomas.The latest application filed is for "remdesivir treatment methods".
Patent | Date |
---|---|
Remdesivir Treatment Methods App 20220175805 - Cihlar; Tomas | 2022-06-09 |
Remdesivir Treatment Methods App 20210393653 - Cihlar; Tomas | 2021-12-23 |
Methods For Treating Sars Cov-2 Infections App 20210283150 - Cihlar; Tomas ;   et al. | 2021-09-16 |
Capsid Inhibitors For The Prevention Of Hiv App 20210188815 - Bekerman; Elena ;   et al. | 2021-06-24 |
Multispecific Antibodies That Target Hiv Gp120 And Cd3 App 20200377592 - Cihlar; Tomas ;   et al. | 2020-12-03 |
Topical Antiviral Formulations App 20200069708 - Cihlar; Tomas ;   et al. | 2020-03-05 |
Multispecific Antibodies That Target Hiv Gp120 And Cd3 App 20180371086 - Cihlar; Tomas ;   et al. | 2018-12-27 |
Compounds and combinations for the treatment of HIV Grant 10,059,697 - Cihlar , et al. August 28, 2 | 2018-08-28 |
Topical Antiviral Formulations App 20180042946 - Cihlar; Tomas ;   et al. | 2018-02-15 |
Compounds And Combinations For The Treatment Of Hiv App 20170114048 - Cihlar; Tomas ;   et al. | 2017-04-27 |
Topical Antiviral Formulations For Prevention Of Transmission Of Hsv-2 App 20130216590 - Karim; Quarraisha Abdool ;   et al. | 2013-08-22 |
Prodrugs of phosphonate nucoleotide analogues Grant 7,803,788 - Becker , et al. September 28, 2 | 2010-09-28 |
Isolated hOAT polynucleotide Grant 7,589,186 - Cihlar September 15, 2 | 2009-09-15 |
Prodrugs Of Phosphonate Nucleotide Analogues App 20080227754 - Becker; Mark W. ;   et al. | 2008-09-18 |
Prodrugs of phosphonate nucleotide analogues Grant 7,390,791 - Becker , et al. June 24, 2 | 2008-06-24 |
Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis App 20070281911 - Cihlar; Tomas ;   et al. | 2007-12-06 |
Method and compositions for identifying anti-hiv therapeutic compounds App 20070190523 - Birkus; Gabriel ;   et al. | 2007-08-16 |
Isolated hOAT polypeptide Grant 7,071,305 - Cihlar July 4, 2 | 2006-07-04 |
Method and compositions for identifying anti-hiv therapeutic compounds App 20060115815 - Birkus; Gabriel ;   et al. | 2006-06-01 |
Isolated hOAT polypeptide App 20060099683 - Cihlar; Tomas | 2006-05-11 |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same App 20060024659 - Becker; Mark W. ;   et al. | 2006-02-02 |
Method and compositions for identifying anti-HIV therapeutic compounds App 20050239054 - Arimilli, Murty N. ;   et al. | 2005-10-27 |
Methods of inhibition of MMTV-like viruses App 20050239753 - Cihlar, Tomas ;   et al. | 2005-10-27 |
Prodrugs of phosphonate nucleotide analogues App 20050159392 - Becker, Mark W. ;   et al. | 2005-07-21 |
Prodrugs of phosphonate nucleotide analogues App 20050124584 - Becker, Mark W. ;   et al. | 2005-06-09 |
Prodrugs of phosphonate nucleotide analogues App 20050124585 - Becker, Mark W. ;   et al. | 2005-06-09 |
Prodrugs of phosphonate nucleotide analogues App 20050009043 - Becker, Mark W. ;   et al. | 2005-01-13 |
Method and compositions for identifying anti-HIV therapeutic compounds App 20040121316 - Birkus, Gabriel ;   et al. | 2004-06-24 |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same App 20040018150 - Becker, Mark W. ;   et al. | 2004-01-29 |
Novel gene encoding organic anion transporter App 20030106075 - Cihlar, Tomas | 2003-06-05 |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same App 20020119443 - Becker, Mark W. ;   et al. | 2002-08-29 |
Gene encoding organic anion transporter Grant 6,432,631 - Cihlar August 13, 2 | 2002-08-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.